Bibliographic Details
| Title: |
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells. |
| Authors: |
Lafontaine, Julie1 (AUTHOR) julie.lafontaine.chum@ssss.gouv.qc.ca, Cardin, Guillaume B.1 (AUTHOR) cardinguill@gmail.com, Malaquin, Nicolas1 (AUTHOR) nico.malaquin@gmail.com, Boisvert, Jean-Sébastien1,2 (AUTHOR) jean-sebastien.boisvert@umontreal.ca, Rodier, Francis1,3 (AUTHOR) rodierf@mac.com, Wong, Philip1,4,5,6 (AUTHOR) Philip.Wong@rmp.uhn.ca, Nakamura, Tomoki (AUTHOR) |
| Source: |
Cancers. Feb2021, Vol. 13 Issue 3, p386. 1p. |
| Subject Terms: |
*CYTOKINES, *CELL culture, *DNA, *APOPTOSIS, *CELLULAR aging, *CELL survival, *SOFT tissue tumors, *CELL proliferation, *CELL lines, *INFLAMMATORY mediators, *SARCOMA |
| Abstract: |
Simple Summary: Limited volumetric change after pre-operative radiotherapy (RT) suggests that sarcomas generally do not undergo cell death. Senolytic drugs represent a highly promising field as a new therapy approach to drive senescent cancer cells towards cell death to enhance treatment response. Here, we demonstrate that the Bcl-2 family of anti-apoptotic proteins in irradiated senescent sarcoma cells represents a senotherapeutic target to improve the cell death response in RT. This study paves the way for new treatment options in soft tissue sarcoma management. Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly utilized. However, despite improvements in RT accuracy, the rate of local recurrence remains high and is the major cause of death for patients with STS. A better understanding of cell fates in response to RT could provide new therapeutic options to enhance tumour cell killing by RT and facilitate surgical resection. Here, we showed that irradiated STS cell cultures do not die but instead undergo therapy-induced senescence (TIS), which is characterized by proliferation arrest, senescence-associated β-galactosidase activity, secretion of inflammatory cytokines and persistent DNA damage. STS-TIS was also associated with increased levels of the anti-apoptotic Bcl-2 family of proteins which rendered cells targetable using senolytic Bcl-2 inhibitors. As oppose to radiation alone, the addition of senolytic agents Venetoclax (ABT-199) or Navitoclax (ABT-263) after irradiation induced a rapid apoptotic cell death in STS monolayer cultures and in a more complex three-dimensional culture model. Together, these data suggest a new promising therapeutic approach for sarcoma patients who receive neoadjuvant RT. The addition of senolytic agents to radiation treatments may significantly reduce tumour volume prior to surgery and thereby improve the clinical outcome of patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
